Coni-Snap® Sprinkle Capsules

A new generation of consumer-centric capsules specifically designed to meet the needs of a rapidly growing population that have difficulty swallowing. Available in gelatin and HPMC.

Consumer Health & Nutrition Applications
Biopharmaceutical Applications

Easy to Open and Easy to Fill

The main issue when using standard hard capsules is their strong locking mechanism requiring sufficient grip strength and dexterity to reopen the capsule. Coni-Snap sprinkle capsules have an innovative closure that needs less force to open so it can be opened much easier and safer. Based on the trusted Coni-Snap® design, it can be filled on the same machines as traditional capsules but will remain in place during packaging and transportation.

Proven Easy to Use by Consumers

Consumer tests have confirmed that Coni-Snap sprinkle capsules are easier to open than traditional capsules. Including parents, caregivers, and elderly patients, 81% of participants described the design as easy or very easy to open.

Evaluation of easiness to open. Product was evaluated by 37 participants in three panels including parents of young children and elderly (non-impaired) people over 80.

Coni-Snap® Sprinkle design
81%
Regular Design
29%
Interested in learning more about Coni-Snap® Sprinkle Capsules?
Contact Us
Early development screening for technology selection and formulation design
In this webinar, we will present data from in vitro analyses that can be examined in the context of in vivo absorption with an early-phase absorption calculator. Join us now to learn more!
View
Hard to Swallow? Novel Solutions for Pediatrics and Patients who can't swallow pills.
View
Study of consumer preferences: Solid oral dosage forms
View White Paper
Meeting The Needs Of The Older Patient Through Advanced Product Development And Design

Drug product development is traditionally being done on a single compound in patients with a single disease or at least strictly randomized and surveyed. This often misses the "real patients" and major user group to which 70 % in volume of our drugs are prescribed to - the patients beyond 65 years. This webinar draws a basic picture on the real older patients and their needs in complex drug therapy and discuss how this translates into advanced product development and design.

View Webinar